The Pyroptosis-Related Risk Genes APOBEC3D, TNFRSF14, and RAC2 Were Used to Evaluate Prognosis and as Tumor Suppressor Genes in Breast Cancer

Figure 8

The pyroptosis-related signature has a good evaluation effect on the tumour microenvironment score and checkpoint therapy. The heatmap was used for evaluation (a). The tumour microenvironment score and (b). Immune cells. (c-j). The pyroptosis-related signature has a good evaluative effect in a checkpoint therapy.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)